+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
VENMAX VENMAX

Venmax Drugs & Pharmaceuticals Share Price

₹16.84 -0.16 (-0.94%)
54.44% Fall from 52W High

04 Aug, 2026 4:01 PM (IST)

Venmax Drugs & Pharmaceuticals live price: ₹16.84. It opened at ₹17 vs previous close ₹17; intraday high/low: ₹17/₹16. The 50 & 200 DMA stand at ₹19.20/₹22.70.

Venmax Drugs & Pharmaceuticals Performance

  • Today's Low
  • ₹16
  • Today's High
  • ₹17
  • 52 Week Low
  • ₹16
  • 52 Week High
  • ₹37
  • Open Price₹17
  • Previous Close₹17
  • Volume8,392
  • 50 DMA₹19.20
  • 100 DMA₹21.20
  • 200 DMA₹22.70

Venmax Drugs & Pharmaceuticals Chart

Investment Returns

  • Over 1 Month -11.09%
  • Over 3 Month -31.29%
  • Over 6 Month -31.68%
  • Over 1 Year -33.04%

Smart Investing Starts Here Start SIP with Venmax Drugs & Pharmaceuticals for Steady Growth!

Invest Now

Venmax Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 73.5
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 15
  • P/B Ratio
  • 1.3
  • Average True Range
  • 2.2
  • EPS
  • 0.2
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.6
  • RSI
  • 44.48
  • MFI
  • 37.13

Latest Stock News Updates

Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.

Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Unaudited financial results for the quarter ended June 30, 2026.

Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Allotment

Allotment of 7,53,334 Convertible warrants in to Equity Shares on Preferential basis pursuant to Regulation 30 read with schedule III of SEBI LODR Regulation, 2015.

Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Allotment

Allotment of 21,47,665 Convertible warrants in to Equity shares on preferential basis pursuant to Regulation 30 read with Schedule III of SEBI LODR Regulation, 2015.

Venmax Drugs & Pharmaceuticals Financials

Venmax Drugs & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹16.84
-0.16 (-0.94%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹17.60
  • 50 Day
  • ₹19.20
  • 100 Day
  • ₹21.20
  • 200 Day
  • ₹22.70

Resistance and Support

16.65 Pivot Speed
  • R3 18.10
  • R2 17.50
  • R1 17.20
  • S1 16.30
  • S2 15.80
  • S3 15.40

Venmax Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-07 Quarterly Results
2026-05-14 Audited Results
2026-02-07 Quarterly Results
2025-11-12 Quarterly Results
2025-09-02 Amalgamation & A.G.M.

Venmax Drugs & Pharmaceuticals Shareholding Pattern

89.53%
10.46%
0%

About Venmax Drugs & Pharmaceuticals

Venmax Drugs & Pharmaceuticals is engaged in the business of pharmaceutical products, drug intermediaries and API’s . View More
  • NSE Symbol
  • VENMAX
  • BSE Symbol
  • 531015
  • ISIN
  • INE154G01022

Similar Stocks to Venmax Drugs & Pharmaceuticals

Venmax Drugs & Pharmaceuticals FAQs

Venmax Drugs & Pharmaceuticals share price is ₹16 As on 04 August, 2026 | 22:07

The Market Cap of Venmax Drugs & Pharmaceuticals is ₹14.8 Cr As on 04 August, 2026 | 22:07

The P/E ratio of Venmax Drugs & Pharmaceuticals is 73.5 As on 04 August, 2026 | 22:07

The PB ratio of Venmax Drugs & Pharmaceuticals is 1.3 As on 04 August, 2026 | 22:07

The 52 week High & Low of Venmax Drugs & Pharmaceuticals is ₹37/₹15.6 respectively As on 04 August, 2026 | 22:07

Open FREE Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23